Grants for Private institutions of higher education - Federal

This funding opportunity provides financial support to organizations that create and manage equine therapy programs aimed at improving the well-being and quality of life for disabled veterans and members of the Armed Forces.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the RNA Modifications Driving Oncogenesis (RNAMoDO) Initiative. It aims to promote mechanistic research in the emerging area of RNA modifications that drive oncogenesis, with a focus on the central role of RNA modifications in translational reprogramming of cancer cells. RNA modifications have been recognized to exert a substantial impact on gene expression and function and their de-regulation has been linked to the cancer phenotype. In particular, recent insights point to a crucial role for mRNA, tRNA, and rRNA modifications in translational reprogramming during tumor initiation, progression, and adaptation to therapy. However, the molecular mechanisms underlying this reshaping of the translatome caused by dynamic changes in RNA modifications, and especially the interplay between different RNA modifications within and across RNA molecules during translation, are not understood and represent the focus of this initiative. Historically, the research community has largely pursued investigations of RNA modifications by studying single RNA species and modification types. However, elucidating how dysregulation of mRNA, tRNA, and rRNA modifications reprograms translation to drive oncogenesis is not likely feasible for any single research laboratory, but will require the combination of expertise in mRNA, tRNA and rRNA biology, translational regulation, and cancer research. To stimulate progress in this emerging field, the RNAMoDO program will support collaborative research projects, preferably using an MPI structure, on how modifications in mRNA, tRNA, and rRNA molecules can drive the oncogenic process through translational reprogramming. To be responsive to the NOFO, each project will also explore the impact of interactions between modifications residing on the same or different RNA molecules during translation. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in the early Fall of 2024, with an expected application due date in November 2024. The NOFO will utilize the U01 mechanism for Research Project Cooperative Agreement (Clinical Trial Not Allowed). Potential applicants are encouraged to view the presentation of this initiative to the NCI Board of Scientific Advisors (BSA), available at: (https://videocast.nih.gov/watch=54423) beginning at 1 hour, 32 minutes, 52 seconds. Presentation slides are downloadable at https://deainfo.nci.nih.gov/advisory/bsa/0324/Maas.pdf.

This funding opportunity is designed to support partnerships that help low-income students successfully transition from middle school to college through mentoring, academic support, and financial aid education.

This grant provides funding to nonprofit organizations in Sri Lanka to support the establishment and operation of American Corner Jaffna, focusing on English language proficiency, cultural exchange, and leadership development for youth.

The U.S. Department of State, Bureau of Democracy, Human Rights, and Labor (DRL) announces an open competition for a new project, Dignity in Documentation Initiative (DIDI). This effort focuses on global, integrated, and holistic CRSV documentation programming seeking truth and justice for victims and survivors as well as accountability for crimes committed in violation of international human rights and humanitarian law. The DIDI must take a survivor-centered and trauma-informed approach, prioritizing the individual needs and efforts of CRSV survivors, while supporting survivor networks, civil society, and community-based organizations. This solicitation will result in the first tranche of these program efforts, with incremental funding envisioned over the life of the 5-year project, depending on the availability of funding.

The key aspects of this award are: Impact: The SRA is intended to support research designed to have a major impact on the health and well-being of melanoma survivors, their families, and/or caregivers. Impactful research will accelerate the movement of promising ideas into clinical applications or other real-world applications and advance the field of melanoma-specific quality of life and survivorship. Study Design: Applications should clearly articulate and justify the chosen study design. Studies proposing retrospective analyses or prospective enrollment should clearly describe the architecture of the study (e.g., descriptive, correlational, field experimental, meta-analyses) and the study population(s). The study population(s) should be representative of the people who are anticipated to benefit from the research. If applicable, questionnaires should be described in sufficient detail to justify interpretation of potential results. Melanoma Consumer Collaboration: For the purposes of the SRA, a melanoma consumer is defined as a melanoma survivor, family member, and/or caregiver who can provide lived experience expertise to the research project team. Applicants to the SRA are required to establish a collaborative research approach with the melanoma consumer community to maximize the impact and translatability of the research for the benefit of the intended melanoma community(ies). The research team must include at least one melanoma consumer or a melanoma-community supporting organization who will be integral to the planning, execution, and implementation of the proposed research. The role of the melanoma consumer collaborator(s) should include providing objective input on the research question being addressed; the study design, execution, and evaluation; and the potential impact of the research outcomes on the health and well-being of melanoma survivors, their families, and/or their caregivers. The melanoma consumer collaborator(s) should be active participants and integrated into the research team; their participation should not be limited only to passive activities (e.g., attending seminars or quarterly team meetings). Additional information and resources for establishing a collaborative research approach with the melanoma consumer community is provided below.Other Important Considerations:Collaborative Research Approaches: Collaborative research approaches create partnerships between scientific researchers and, for the purposes of the SRA, melanoma consumers to create knowledge useable by both sets of stakeholders. Recognizing the strengths of each partner, scientific researchers and melanoma consumers collaborate and contribute equitably on all aspects of the project, which may include needs assessment, planning, research intervention design, implementation, evaluation, and dissemination. Collaborative research approaches feature shared responsibility and ownership for the research project to ensure non-tokenistic involvement of the melanoma consumers within the research team. Research results are jointly interpreted, disseminated, and fed back to affected communities and in some instances may be translated into interventions or policy.Collaborative relationships with the melanoma consumer community may be established through integrating melanoma consumers and/or melanoma-community supporting organizations into research teams as co-researchers, advisors, and/or consultants. Examples for implementing collaborative research approaches are listed below, but each research team may pursue other options as appropriate for the proposed research: The research team includes at least one melanoma consumer who will provide advice and consultation throughout the planning and implementation of the research project. The consumer(s) should be able to speak to the needs of the melanoma consumer community, not just speak to their own personal experiences. The research team establishes partnerships with at least one community-supporting organization that provides advice and consultation throughout the planning and implementation of the research project. Community-supporting organizations may include advocacy groups or other formal organizational stakeholders that can speak to the needs of the melanoma consumer community. The research team assembles a melanoma consumer community advisory board. The advisory board may include melanoma consumers, a coalition of community-supporting organizations, or any combination thereof that provides advice and consultation throughout the planning and implementation of the overall program and/or individual research projects.

This funding opportunity supports not-for-profit organizations and educational institutions in the UAE to develop programs that strengthen U.S.-UAE relations through cultural events, space exploration initiatives, and entrepreneurship activities.

This funding opportunity supports cultural, educational, and informational initiatives that promote mutual understanding and cooperation between the United States and the Philippines, targeting not-for-profit organizations and educational institutions.

This grant provides funding to organizations in South Korea to strengthen collaboration in shipbuilding and maritime sectors between the U.S. and South Korea through research, networking, and policy development activities.

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (US).

The U.S. Fish and Wildlife Service (FWS) is the premier government agency dedicated to the conservation, protection, and enhancement of fish, wildlife and plants, and their habitats. We are the only agency in the federal government whose primary responsibility is the conservation and management of these important natural resources for the American public.FWS origins date back to 1871 when Congress established the U.S. Fish Commission to study the decrease in the nations food fishes and recommend ways to reverse that decline. Today, we are a diverse and largely decentralized organization, employing about 8,000 dedicated professionals working out of facilities across the country, including a headquarters office in Falls Church, Virginia, and eight Regional offices.The National Infrastructure Partnerships initiative of the US Fish and Wildlife Service (FWS) encourages National Wildlife Refuge System field stations to partner with local, regional, and national nonprofit organizations, other land management groups, state and tribal partners, and others to accomplish projects that:i. promote the stewardship of Refuge System resources through habitat maintenance, restoration, and improvement, andii. support the operation and maintenance of the Refuge System through constructing, operating, maintaining, or improving the facilities and services of the Refuge System.The goals of the initiative are to enable local communities to play a more active role in increasing outdoor recreation opportunities on refuge lands and waters, to be more focused and deliberate in using partnerships to help FWS address infrastructure repair and improvement needs such as proactive maintenance and the maintenance backlog, and to enhance wildlife habitat.Additionally, this initiative can help address multiple FWS priorities as a catalyst for:Economic and Conservation EnhancementCareer Training and Mentoring Opportunities for Youth and AdultsEquity and Inclusion in Conservation and RecreationClimate and Wildlife ResilienceCommunity HealthSuccessful projects will address identified FWS priorities or projects at FWS sites that enhance the visitor experience, promote wildlife-dependent outdoor recreation, provide sustainable wildlife habitat, provide career training and mentoring opportunities, and engage the community in opportunities to participate in wildlife-dependent outdoor recreation on FWS lands and waters.See Full Announcement for additional eligibility requirements.

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. To accomplish the stated overarching goal, this FOA will provide support to recipients of Clinical and Translational Science Awards (CTSA) for creative educational activities with a primary focus on research experiences designed to ensure that the participants receive exposure to the scientific and operational principles underlying each step of the translational process so that they can apply these principles to clinical and translational science research areas such as: 1) pre-clinical research, 2) clinical research, 3) clinical implementation, and 4) public health.

The Office of Citizen Exchanges, Youth Programs Division of the Bureau of Educational and Cultural Affairs (ECA) announces an FY 2024 open competition for three distinct regional Youth Ambassadors programs (previously called Youth Leadership Programs) with select countries in East Asia and Pacific (EAP), Europe and Eurasia (EUR), and the Middle East and North Africa (NEA). U.S. public and private non-profit organizations meeting the provisions described in Internal Revenue Code section 26 USC 501(c)(3) may submit proposals to provide participants with four-week exchanges in the United States focused on the primary themes of civic education, leadership development, respect for diversity, and community engagement and to support the implementation of service projects in their home communities. The EAP and NEA programs also will engage approximately 3-5 adult mentors in programming alongside youth participants. Competitively selected U.S. secondary students will join participants in U.S.-based activities on the NEA exchanges. Only one proposal per region will be considered by ECA from each applicant organization. In cases where more than one submission per region from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review for the region from that applicant. Please see the full announcement for additional information.

The purpose of this SAMHSA program is to prevent and reduce alcohol use among youth and young adults ages 12-20 in communities throughout the United States. The program aims to: (1) address norms regarding alcohol use by youth, (2) reduce opportunities for underage drinking, (3) create changes in underage drinking enforcement efforts, (4) address penalties for underage use, and/or (5) reduce negative consequences associated with underage drinking (e.g., motor vehicle crashes, sexual assaults). In addition, applicants will build on strategic plans that were developed under a Drug Free Communities (DFC) grant.

This funding opportunity provides up to $1.3 billion to support the development and demonstration of advanced carbon capture technologies for power generation and industrial sectors, targeting a wide range of eligible applicants including educational institutions, nonprofits, and businesses.

This funding opportunity provides financial support to local governments, educational institutions, tribal governments, and nonprofit organizations in Colorado for projects aimed at reducing wildfire risks and enhancing community resilience against wildfires.

This funding opportunity provides financial support for small-scale biomedical research projects at institutions with limited NIH funding, focusing on enhancing research experiences for health professional, undergraduate, and graduate students.

The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.

This program provides funding to public bodies, nonprofit organizations, and government entities to support economic development and job creation initiatives in rural areas with populations under 50,000.

This funding opportunity provides financial support to nonprofit organizations, educational institutions, and government entities to establish and operate manufacturing extension centers that assist small and medium-sized manufacturers in eight U.S. states.